Panoply™ Human IL2 Knockdown Stable Cell Line

T cells are key players in the adaptive immune response against pathogens and malignant cells. While alternative splicing plays a crucial role in T-cell activation, previous studies have primarily focused on later time points following stimulation. Here, researchers identified a two-hour window during the early stages of stimulation when optimal splicing efficiency-and, more broadly, gene expression efficiency-is critical for successful T-cell activation. Reducing splicing efficiency between 4 and 6 hours post-stimulation significantly inhibited mouse T-cell activation, a process dependent on the expression dynamics of the Egr1–Nab2–interleukin-2 (IL-2) pathway. This time window coincides with the peak of de novo IL-2 transcription; the researchers propose that this serves as a critical "permissive window" during which reduced splicing (or transcription) efficiency leads to decreased production of mature IL-2, thereby impeding mouse T-cell activation. Notably, significant differences in the expression dynamics of the Egr1–Nab2–IL-2 pathway between mice and humans render human T cells resistant to this vulnerability. The researchers suggest that precise temporal regulation of splicing or transcription during the peak of de novo expression of key effector molecules could be used to fine-tune stimulus-dependent biological outcomes. These data also underscore the need for caution when extrapolating findings from mouse models to human systems in both basic and translational research.

To determine whether IL-2 acts as an effector molecule, the researchers generated IL-2 knockdown EL4 cells (Figure 1D). Subsequently, they subjected these IL-2 knockdown EL4 cells to time-specific splicing inhibition using Pld B. Reducing IL-2 levels not only decreased the total number of viable cells following stimulation (Figure 1E) but also rendered the stimulated EL4 cells resistant to splicing inhibition (Figure 1F). The researchers further conducted rescue experiments using primary mouse T cells by supplementing the culture medium with IL-2 during the time-specific splicing inhibition assay. The results showed that splicing inhibition had no significant effect in the presence of exogenous IL-2, indicating that the supplemented IL-2 compensated for the deficit caused by reduced splicing efficiency in the primary mouse T cells (Figure 1G). Thus, a defect in IL-2 splicing appears to be the primary reason why mouse T cells are susceptible to splicing inhibition between 4 and 6 hours post-stimulation. IL-2 possesses anti-apoptotic properties and plays a crucial role in activation-induced T-cell proliferation.

Figure 1. IL-2 mediates the sensitivity to splicing inhibition sensitivity. (Bose D, et al., 2019)